Ignite Creation Date:
2024-05-06 @ 7:36 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06062485
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-02
First Post:
2023-09-25
Brief Title:
Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma
Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ampullary Carcinoma |
Keywords: